New Patient Appointment or 214-645-8300

Biography

Kelly Chin, M.D., is an Assistant Professor of Internal Medicine and Director of the Pulmonary Hypertension Program at UT Southwestern Medical Center. She specializes in treatment and research of pulmonary hypertension.

Dr. Chin attended UT Southwestern for her medical degree and her residency in internal medicine. She went to the University of California, San Diego, for a fellowship in pulmonary, critical care, and pulmonary hypertension. She joined the UT Southwestern faculty in 2005.

She conducts clinical research into pulmonary hypertension treatments, markers of prognosis, and risk factors for pulmonary hypertension, such as methamphetamine use.

Dr. Chin is board certified in internal medicine, pulmonary disease, and critical care medicine by the American Board of Internal Medicine.

She was named a Super Doctor by Texas Monthly in 2018.

See More

Meet Dr. Chin

Pulmonary Hypertension Specialist

When pulmonologist Kelly Chin, M.D., started treating patients with pulmonary hypertension, it was a newly treatable disease – only six years before, there were no effective treatment options for most people with the disease.

"We offer access to the best treatments for pulmonary hypertension."

Since then, she's witnessed multiple advances in treatment options for patients who suffer from this often fatal disease. The opportunity for her patients to live a better life motivates her.

"After we've started them on therapy, we can see patients get better and really respond in a positive way,” she says. “It's very rewarding as a physician to impact someone's life in that way."

As Director of UT Southwestern Medical Center's Pulmonary Hypertension Program, Dr. Chin has also seen the Program grow quickly. It now ranks among the largest centers in the country, providing access to state-of-the-art treatments.

In addition to clinical care, Dr. Chin spends time researching causes and new treatments for pulmonary hypertension. While experts have identified some risk factors for the disease such as medication exposures and certain genes, there is a need to learn more. Dr. Chin is exploring other potential causes, such as a possible connection between stimulant use and pulmonary hypertension.

Dr. Chin loves seeing the impact new therapies can have on her patients. A pulmonary hypertension diagnosis no longer means a patient is going to die within a few years, she says.

"While it’s still a serious condition, many people improve and feel a lot better,” Dr. Chin notes. “It's certainly treatable. Patients can achieve a significant improvement in quality-of-life with medication. "

 

See More

Education & Training
  • Residency - UT Southwestern Medical Center (1997-2000), Internal Medicine
  • Fellowship - University of California at San Diego School of Medicine (2002-2005), Pulmonary Diseases & Critical Care Medicine
  • Medical School - UT Southwestern Medical School (1992-1996)
Professional Associations & Affiliations
  • Pulmonary Hypertension Association
  • American Thoracic Society
  • American Medical Association
  • American College of Chest Physicians
Honors & Awards
  • College of Natural Science Dean’s Honor List 1989-1992 1990
  • Southwestern Medical Foundation Medical School Scholarship 1992-1996 1992
  • College of Natural Sciences College Scholar Award 1992
  • Finalist, Alfred Soffer Research Award 2007, ACCP Original Research Award
Books & Publications
Research
  • Pulmonary Hypertension

Clinical Focus

  • Lung (Pulmonary) Disorders
  • Pulmonary Hypertension

See More

Q&A by Kelly Chin, M.D.

Showing 7 locations

Pulmonary Hypertension

at UT Southwestern Monty and Tex Moncrief Medical Center at Fort Worth 600 South Main Street, 2nd Floor, Suite 2.400
Fort Worth, Texas 76104
817-882-2420 Directions

University Hospital Heart and Lung Clinic

at Professional Office Building 2 5939 Harry Hines Blvd., 6th Floor, Suite 600
Dallas, Texas 75390
214-645-5505 Directions Parking Info